Christiana Smith, Adriana Weinberg, Jeri E. Forster, Myron J. Levin, Jill Davies, Jennifer Pappas, . . . Elizabeth J. McFarland. (2016). Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir. Hindawi Limited.
Chicago Style (17th ed.) CitationChristiana Smith, et al. Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir. Hindawi Limited, 2016.
MLA (9th ed.) CitationChristiana Smith, et al. Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir. Hindawi Limited, 2016.
Warning: These citations may not always be 100% accurate.